Back to Search Start Over

Continuous ST-Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease.

Authors :
Watanabe T
Hirooka K
Furukawa Y
Yabuki M
Hirata A
Kashiwase K
Shutta R
Mine T
Mizuno H
Tanaka T
Doi T
Yoshida A
Okuyama Y
Nanto S
Source :
Journal of the American Heart Association [J Am Heart Assoc] 2018 Jun 30; Vol. 7 (13). Date of Electronic Publication: 2018 Jun 30.
Publication Year :
2018

Abstract

Background: Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST-monitoring function in coronary artery disease patients.<br />Methods and Results: We conducted a prospective study of implantable cardioverter defibrillator patients with the ST-monitoring function. One hundred seventy-three patients who received implantable cardioverter defibrillators for primary or secondary prevention of sudden cardiac death. All patients underwent medical examinations at least every 6 months, with standard 12-lead ECGs and device checks that included analysis of the ST-monitoring function. Myocardial perfusion imaging or coronary angiography was performed during the follow-up. The mean follow-up duration was 23.3±7.7 months. Significant ST changes occurred in 15 patients (8.7%), of whom 14 were asymptomatic. The incidence of angina pectoris was significantly higher in the ST change (+) group than that in the ST change (-) group (28.6% versus 7.2%, P =0.03). In the patients who underwent myocardial perfusion imaging, the sensitivity, specificity, and negative predictive value of the ST-monitoring feature to detect ischemia were 75.0%, 72.5%, and 93.5%, respectively. The sensitivity, specificity, and negative predictive value of the ST-monitoring feature to predict residual stenosis evaluated using coronary angiography were 76.9%, 83.5%, and 97.5%, respectively. The percentage of patients with a septal right ventricular lead was significantly lower in the ST change (+) group than in the ST change (-) group (13.5% versus 33.5%, P =0.01).<br />Conclusions: If intracardiac ECGs ST changes are detected, it is necessary to use additional modalities even in asymptomatic patients.<br />Clinical Trial Registration: URL: upload.umin.ac.jp. Unique identifier: UMIN000011824.<br /> (© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.)

Details

Language :
English
ISSN :
2047-9980
Volume :
7
Issue :
13
Database :
MEDLINE
Journal :
Journal of the American Heart Association
Publication Type :
Academic Journal
Accession number :
29960992
Full Text :
https://doi.org/10.1161/JAHA.118.009332